Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP Nerve Block for Intractable Postherpetic Neuralgia
NCT05444413Phase 1Completed
- Sponsor
- Affiliated Hospital of Nantong University
- Start
- Mar 2022
- Primary completion
- May 2022
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of platelet-rich plasma in postherpetic neuralgia (PHN), sponsored by Affiliated Hospital of Nantong University. Primary endpoint: Numerical Rating Scale at 6 months. Started Mar 2022; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT05444413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05444413.